| TGFA antibodies | |
| This is a review about transforming growth factor alpha antibodies, based on 4 published articles using transforming growth factor alpha antibodies in western blot, immunohistochemistry, immunoprecipitation, immunocytochemistry, and other immunological technologies. It is aimed to help ExactAntigen visitors find the most suited transforming growth factor alpha antibody. Information in this review (with links to publications) can be searched freely. |
R & D SYSTEMS search R & D Systems TGFA products
includes other brands or spellings
|
| block | | R&D Systems Europe goat polyclonal anti-human TGF alpha antibody was used in human non-small cell lung cancer cell lines and in blocking expriments to study the mechanism of apoptosis inhibition by amphiregulin through an IGF1-dependent survival pathway in non-small cell lung cancer (NSCLC) cells. |
| elisa | | R&D Systems Quantikine human TGF alpha immunoassay kit was used to study the differing effect of HIF1 and HIF2 in von Hippel-Lindau-Associated renal cell carcinoma. |
EMD BIOSCIENCES search EMD Biosciences TGFA products
includes other brands or spellings
|
| ih | | Oncogene Research Products anti-TGF-alpha monoclonal antibody was used in immunohistochemistry to study the production of interleukin 15 by human colon cancer cells associated with induction of mucosal hyperplasia, angiogenesis, and metastasis. |
BIOTOPE
|
| ih | | BioTope anti-TGFalpha antibody was used in immunohistochemistry to reveal the intricate relationships between affinity and mitogenicity by studying the characterization of epigen which is the last ligand of ErbB receptors. |
Articles Reviewed |
| 1. Amandine Hurbin et al. Inhibition of apoptosis by amphiregulin via an insulin-like growth factor-1 receptor-dependent pathway in non-small cell lung cancer cell lines. 2002 |
| 2. Hiroki Kuniyasu et al. Production of interleukin 15 by human colon cancer cells is associated with induction of mucosal hyperplasia, angiogenesis, and metastasis. 2003 |
| 3. Bose S Kochupurakkal et al. Epigen, the last ligand of ErbB receptors, reveals intricate relationships between affinity and mitogenicity. 2005 |
| 4. Raju R Raval et al. Contrasting properties of hypoxia-inducible factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-associated renal cell carcinoma. 2005 |
|